XW043H5Billable procedure code
Introduction of Tocilizumab into Central Vein, Percutaneous Approach, New Technology Group 5
New Technology·Anatomical Regions·Table XW0·FY 2027
ICD-10-PCS classifies this procedure as XW043H5: Introduction of Tocilizumab into Central Vein, Percutaneous Approach, New Technology Group 5. Table XW0, part of Section X (New Technology) contains it. The procedure targets the Anatomical Regions body system. The approach used is Percutaneous.
Advertisements
What the code means
Introduction: root operation
Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products
Percutaneous: approach
Entry, by puncture or minor incision, of instrumentation through the skin or mucous membrane and any other body layers necessary to reach the site of the procedure
Nearby codes in table XW0
- Previous: XW043G7 Introduction of Allogeneic Engineered Chimeric Antigen Receptor T-cell Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 7
- Next: XW043H6 Introduction of Other New Technology Monoclonal Antibody into Central Vein, Percutaneous Approach, New Technology Group 6